Bayer HealthCare Pharmaceuticals: Bayer HealthCare Grants4Targets Initiative

Bayer HealthCare allocates grants for the exploration of attractive, novel drug targets in the fields of:
- Oncology: Focus on anti-proliferative, survival signaling, transcription and chromatin modulation, cell cycle regulation, tumor metabolism, hypoxia, immunotherapy and antibody-drug conjugates;
- Gynecology: Focus on novel treatment options for endometriosis (incl. adenomyosis uteri/endometriosis interna) and uterine fibroids (uterine leiomyoma);
- Cardiology: Focus on novel approaches to the care of chronic and/or acute pulmonary hypertension, atrial fibrillation, heart failure, acute coronary syndrome, ischemic stroke, peripheral arterial occlusive disease, acute lung injury/adult respiratory distress syndrome, cardiorenal syndrome and chronic kidney diseases;
- Hematology: Focus on hemophelia, anemia and thrombocytopenia.
We look forward to hearing about your innovative ideas!
Support Grants (€5,000-€10,000) to further advance research on targets that are at a very early stage of discovery; IP rights remain with the applicant.
Focus Grants (€10,000-€125,000) for more mature ideas, e.g. to address specific aspects of a target as a first step towards transferring it to the drug discovery process; IP rights remain with the applicant.
In addition to the financial grants Bayer may support by providing Antibodies, Small Molecule Tool Compounds, Biobank samples and, Technologies.
http://www.grants4targets.com/scripts/pages/en/index.php